Evidence map›Paper›PMID 37236204›Full record

ArticleACS chemical neuroscience2023

JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding.

Carlos G Ardanaz, Amaia Ezkurdia, Arantza Bejarano, Beatriz Echarte, Cristian Smerdou, Eva Martisova, Iván Martínez-Valbuena, María-Rosario Luquin, María J Ramírez, Maite Solas

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Carlos G ArdanazDepartment of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain.
Amaia EzkurdiaDepartment of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain.
Arantza BejaranoDepartment of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain.
Beatriz EcharteDepartment of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain.
Cristian SmerdouIdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
Eva MartisovaDivision of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, 31008 Pamplona, Spain.
Iván Martínez-ValbuenaIdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
María-Rosario LuquinIdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
María J RamírezDepartment of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain.
Maite SolasDepartment of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-7670-3237
Navarre Institute of Health Research · ESUniversidad de Navarra · ESUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

c-Jun N-terminal kinases (JNKs) are a family of protein kinases activated by a myriad of stimuli consequently modulating a vast range of biological processes. In human postmortem brain samples affected with Alzheimer's disease (AD), JNK overactivation has been described; however, its role in AD onset and progression is still under debate. One of the earliest affected areas in the pathology is the entorhinal cortex (EC). Noteworthy, the deterioration of the projection from EC to hippocampus (Hp) point toward the idea that the connection between EC and Hp is lost in AD. Thus, the main objective of the present work is to address if JNK3 overexpression in the EC could impact on the hippocampus, inducing cognitive deficits. Data obtained in the present work suggest that JNK3 overexpression in the EC influences the Hp leading to cognitive impairment. Moreover, proinflammatory cytokine expression and Tau immunoreactivity were increased both in the EC and in the Hp. Therefore, activation of inflammatory signaling and induction of Tau aberrant misfolding caused by JNK3 could be responsible for the observed cognitive impairment. Altogether, JNK3 overexpression in the EC may impact on the Hp inducing cognitive dysfunction and underlie the alterations observed in AD.

Indexed as

Alzheimer DiseaseCognition DisordersCognitive DysfunctionCognitionEntorhinal CortexHippocampusHumanstau Proteinstau Proteinscognitive impairmententorhinal cortexgliosishippocampusneuroinflammationTau

Identifiers

PMID37236204
PMCPMC10251484
OpenAlexW4378470418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.